Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview

Since we have gained an understanding of the immunological pathophysiology of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, treatment based on biological drugs has become a fundamental axis. These therapies are oriented towards the regulation of cytokines such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Sandra, Muñoz, Andrés, Bustos, Rosa-Helena, Jaimes, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555940/
https://www.ncbi.nlm.nih.gov/pubmed/32842558
http://dx.doi.org/10.3390/biomedicines8090303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555940/
https://www.ncbi.nlm.nih.gov/pubmed/32842558
http://dx.doi.org/10.3390/biomedicines8090303

Ejemplares similares